Who are Cytosorbents Corporation's main suppliers?

Cytosorbents Corporation (CTSO) key suppliers include: Fresenius Medical Care AG, Fresenius Medical Care AG. View the full supplier network at chainsifter.com/chain/CTSO.

Who are Cytosorbents Corporation's major customers?

Cytosorbents Corporation (CTSO) key customers include: DISTRIBUTOR-A, Fresenius Medical Care AG, FRESENIUS-MEDICAL-CARE, DISTRIBUTOR-B, Fresenius Medical Care AG and 9 more. View the full customer network at chainsifter.com/chain/CTSO.

What sector is Cytosorbents Corporation in?

Cytosorbents Corporation (CTSO) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

Cytosorbents Corporation Supply Chain Data (CTSO): 19 Verified Relationships

2Suppliers

14Customers

3Debt Items

19Related Chains

Source-Backed Evidence Depth

Cytosorbents Corporation (CTSO) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

20Total relationships

4Distinct source URLs

14High confidence

0.801Average confidence

2026-10-28Latest database update

ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

Cytosorbents Corporation Suppliers

Ticker	Name	Confidence	Evidence
FMS	Fresenius Medical Care AG	72%	Reciprocal relationship from FMS graph: Reciprocal relationship from CTSO graph: k, and anti-self referral and insurance laws that apply to state-funded Medicaid and other health care programs and pr…
FMS	Fresenius Medical Care AG	72%	k, and anti-self referral and insurance laws that apply to state-funded Medicaid and other health care programs and private third-party payers and some state laws apply regardless of payor (i.e., eve…

Cytosorbents Corporation Customers

Ticker	Name	Confidence	Evidence
DISTRIBUTOR-A	DISTRIBUTOR-A	90%	For the three months ended March 31, 2026, distributor A accounted for approximately 14 % of the Company’s revenue.
FMS	Fresenius Medical Care AG	90%	Reciprocal relationship from FMS graph: Reciprocal relationship from CTSO graph: Reciprocal relationship from FMS graph: Reciprocal relationship from CTSO graph: Reciprocal relationship from FMS grap…
FRESENIUS-MEDICAL-CARE	FRESENIUS-MEDICAL-CARE	90%	In August 2022, we expanded our partnership with Fresenius Medical Care to a global marketing collaboration.
DISTRIBUTOR-B	DISTRIBUTOR-B	85%	As of March 31, 2026, distributor A and distributor B accounted for approximately 17 % and 11 %, respectively, of the Company’s outstanding accounts receivable.
FMS	Fresenius Medical Care AG	85%	d registration, due to other factors such as market adoption, reimbursement and/or geopolitical developments. We continuously evaluate other potential distributor and strategic partner networks in ot…
FRESENIUS-MEDICAL-CARE-AG-B-BRAUN-AVITUM-AG	FRESENIUS-MEDICAL-CARE-AG-B-BRAUN-AVITUM-AG	85%	rsement and/or geopolitical developments. We continuously evaluate other potential distributor and strategic partner networks in other countries that accept CE Mark approval. In addition to our direc…
TERUMO-CARDIOVASCULAR-GROUP	TERUMO-CARDIOVASCULAR-GROUP	85%	senius Medical Care AG, B. Braun Avitum AG, Aferetica s.r.l., and Terumo Cardiovascular Group.
AFERETICA-S-R-L	AFERETICA-S-R-L	80%	senius Medical Care AG, B. Braun Avitum AG, Aferetica s.r.l., and Terumo Cardiovascular Group.
B-BRAUN-AVITUM-AG	B-BRAUN-AVITUM-AG	80%	senius Medical Care AG, B. Braun Avitum AG, Aferetica s.r.l., and Terumo Cardiovascular Group.
SENIUS-MEDICAL-CARE-AG	SENIUS-MEDICAL-CARE-AG	80%	senius Medical Care AG, B. Braun Avitum AG, Aferetica s.r.l., and Terumo Cardiovascular Group.
AVENUE-CAPITAL-GROUP	AVENUE-CAPITAL-GROUP	62%	s to an additional aggregate $ 2.5 million (“Tranche 2b”) from Avenue Capital Group and receive a further six-month extension of the interest only period to the July 1, 2027 maturity date, subject to…
FIELD-READY-BLOOD-GROUP	FIELD-READY-BLOOD-GROUP	62%	specializes in the sale of certain medical products and devices, specifically extracorporeal therapies, in the critical care, cardiac surgery and liver disease markets (“Aferetica”). The agreement wa…
FRESNEIUS-MEDICAL-CARE-AG	FRESNEIUS-MEDICAL-CARE-AG	62%	country distribution and/or co-marketing agreements with Fresneius Medical Care AG dating back to December 2014. Over the years, these agreements have included partnerships to support the commerciali…
ROKK-LLC	ROKK-LLC	62%	specializes in the sale of certain medical products and devices, specifically extracorporeal therapies, in the critical care, cardiac surgery and liver disease markets (“Aferetica”). The agreement wa…

Cytosorbents Corporation Debt Obligations

Instrument	Description	Confidence	Evidence
CTSO-DEBT	Debt stack $17.2M	90%	Market cache reports total debt of $17.2M.
CTSO-DEBT-8921	Warrants outstanding: 816000	90%	xbrl warrant detail from xbrl 2025-12-31.
CTSO-DEBT-8922	Xbrl Convertible	90%	xbrl convertible detail from xbrl 2016-12-31.

Cytosorbents Corporation Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Cytosorbents Corporation.

Cytosorbents Corporation Ownership

Holder	Name	Confidence	Evidence
CTSO-OWNER-AVENIR-CORP	AVENIR CORP	90%	13F overlay lists AVENIR CORP as top holder; 52 tracked holders.

Cytosorbents Corporation Extended Supply Chain Network

Ticker	Name	Chain Index	Hops	Relationship Types
FMS	Fresenius Medical Care AG	100.00	1	['customer', 'supplier']
BAX	Baxter International Inc.	50.00	2
BDX	Becton, Dickinson and Company	50.00	2
CHRS	Coherus Oncology, Inc.	50.00	2
EHC	Encompass Health Corporation	50.00	2
FMCQF	Fresenius Medical Care AG	50.00	2
BSX	Boston Scientific Corporation	50.00	2
HUMAW	Humacyte, Inc.	50.00	2
THC	Tenet Healthcare Corporation	50.00	2
STMEF	STMicroelectronics N.V.	50.00	2
RYLPF	Koninklijke Philips N.V.	50.00	2
MT	ArcelorMittal S.A.	50.00	2
APAM	Artisan Partners Asset Management Inc.	17.45	2
SNYNF	Sanofi	17.45	2
DVA	DaVita Inc.	17.45	2
OM	Outset Medical, Inc.	17.45	2
FSNUY	Fresenius SE & Co. KGaA	17.45	2
TKPHF	Takeda Pharmaceutical Company Limited	17.45	2
HUMA	Humacyte, Inc.	17.45	2

Cytosorbents Corporation Supply Chain